Up until now, there are no RhoA mutations corresponding with cardiac diseases known yet, but there is good evidence for direct correlations between mutations of the RhoA-gene as well as known mediators of RhoA signaling pathways and cancer. The gene discussed is RHOA; the disease is cancer.